What is a stock summary page? Click here for an overview.
Business Description
Creo Medical Group PLC
ISIN : GB00BZ1BLL44
Description
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from Europe and the rest from the United Kingdom and the rest of the world.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.69 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | -0.68 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -0.9 | |||||
| Beneish M-Score | -2.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.1 | |||||
| 3-Year EBITDA Growth Rate | 21 | |||||
| 3-Year EPS without NRI Growth Rate | 17.8 | |||||
| 3-Year FCF Growth Rate | 10.7 | |||||
| 3-Year Book Growth Rate | -24.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 35.23 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | -15.39 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.29 | |||||
| 9-Day RSI | 19.95 | |||||
| 14-Day RSI | 24.4 | |||||
| 3-1 Month Momentum % | -19.81 | |||||
| 6-1 Month Momentum % | -43.71 | |||||
| 12-1 Month Momentum % | -55.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.24 | |||||
| Quick Ratio | 2.38 | |||||
| Cash Ratio | 0.99 | |||||
| Days Inventory | 195.62 | |||||
| Days Sales Outstanding | 98.78 | |||||
| Days Payable | 124.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.2 | |||||
| Shareholder Yield % | -1.85 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.51 | |||||
| Operating Margin % | -82.84 | |||||
| Net Margin % | -73.93 | |||||
| FCF Margin % | -72.15 | |||||
| ROE % | -38.14 | |||||
| ROA % | -28.64 | |||||
| ROIC % | -41.23 | |||||
| 3-Year ROIIC % | -20.52 | |||||
| ROC (Joel Greenblatt) % | -107.14 | |||||
| ROCE % | -36.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.51 | |||||
| PB Ratio | 0.96 | |||||
| Price-to-Tangible-Book | 1.94 | |||||
| EV-to-EBIT | -2.35 | |||||
| EV-to-Forward-EBIT | -3.22 | |||||
| EV-to-EBITDA | -2.73 | |||||
| EV-to-Forward-EBITDA | -3.54 | |||||
| EV-to-Revenue | 1.89 | |||||
| EV-to-Forward-Revenue | 7.81 | |||||
| EV-to-FCF | -2.69 | |||||
| Price-to-GF-Value | 0.36 | |||||
| Price-to-Net-Current-Asset-Value | 4.53 | |||||
| Earnings Yield (Greenblatt) % | -42.78 | |||||
| FCF Yield % | -41.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Creo Medical Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 35.492 | ||
| EPS (TTM) (€) | -0.07 | ||
| Beta | 0.18 | ||
| 3-Year Sharpe Ratio | -0.97 | ||
| 3-Year Sortino Ratio | -1.24 | ||
| Volatility % | 46.23 | ||
| 14-Day RSI | 24.4 | ||
| 14-Day ATR (€) | 0.008527 | ||
| 20-Day SMA (€) | 0.15065 | ||
| 12-1 Month Momentum % | -55.96 | ||
| 52-Week Range (€) | 0.136 - 0.448 | ||
| Shares Outstanding (Mil) | 412.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Creo Medical Group PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Creo Medical Group PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Creo Medical Group PLC Frequently Asked Questions
What is Creo Medical Group PLC(FRA:1RC)'s stock price today?
The current price of FRA:1RC is €0.14. The 52 week high of FRA:1RC is €0.45 and 52 week low is €0.14.
When is next earnings date of Creo Medical Group PLC(FRA:1RC)?
The next earnings date of Creo Medical Group PLC(FRA:1RC) is 2025-04-30 Est..
Does Creo Medical Group PLC(FRA:1RC) pay dividends? If so, how much?
Creo Medical Group PLC(FRA:1RC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers